Ipamorelin, also known as NNC 26-0161, serves as a selective growth hormone-releasing hormone (GHRH) agonist. This synthetic peptide mimics the effects of naturally occurring GHRH, stimulating the pituitary gland to produce growth hormone (GH). Ipamorelin exhibits a high affinity for the GHRH receptor and possesses minimal side effects compared to